Filing Details

Accession Number:
0001225208-17-018664
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-14 16:04:32
Reporting Period:
2017-12-12
Accepted Time:
2017-12-14 16:04:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1494319 Univar Inc. UNVR Wholesale-Chemicals & Allied Products (5160) 261251958
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1644764 John Mark Byrne 15165 Via Del Sur
Monte Sereno CA 95030
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-12-12 49,500 $18.54 63,994 No 4 M Direct
Common Stock Disposition 2017-12-12 49,500 $29.16 14,494 No 4 S Direct
Common Stock Acquisiton 2017-12-13 40,534 $18.54 55,028 No 4 M Direct
Common Stock Disposition 2017-12-13 40,534 $29.10 14,494 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (right to buy) Disposition 2017-12-12 49,500 $0.00 49,500 $18.54
Common Stock Stock Options (right to buy) Disposition 2017-12-13 40,534 $0.00 40,534 $18.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
202,453 2014-02-01 2024-02-01 No 4 M Direct
161,919 2014-02-01 2024-02-01 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.061 to $29.365, inclusive. The Reporting Person understakes to provide Univar Inc., any of its security holders, or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each seperate price within the range set forth in footnotes (1) and (2) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.97 to $29.215, inclusive.
  3. These options were granted on February 1, 2014 and became vested and exercisable in 12 installments beginning on the grant date and ending on Decemember 28, 2014.